At what pace is the salivary gland infection market growing, and what is its estimated value?
The salivary gland infection market size has grown strongly in recent years. It will grow from $4.12 billion in 2024 to $4.46 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to rise in oral health issues, increase in awareness of salivary disorders, growth in prevalence of bacterial and viral infections, expanding healthcare infrastructure, rise in geriatric population, and rise in adoption of minimally invasive treatments.
The salivary gland infection market size is expected to see strong growth in the next few years. It will grow to $6.09 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to rising awareness about oral health, growing adoption of minimally invasive procedures, increasing prevalence of chronic conditions, improvements in healthcare infrastructure, and expansion of patient access to specialized care. Major trends in the forecast period include adoption of minimally invasive procedures, advancements in sialendoscopy techniques, advanced imaging technologies, biocompatible stent developments, adoption of robotic-assisted surgeries, adoption of targeted antimicrobial therapies, and AI-driven diagnostic tools.
Get Your Free Sample of The Global Salivary Gland Infection Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21281&type=smp
What are the top drivers to the rising demand in the salivary gland infection market?
The rise in oral health issues is expected to drive the growth of salivary gland infections market going forward. Oral health issues include conditions such as tooth decay, gum infections, and other mouth-related problems. Poor oral hygiene, unhealthy eating habits, and inadequate dental care access are driving the rise in oral health problems. The rise in oral health issues increases the risk of salivary gland infections by promoting bacterial growth and blockages in the salivary ducts. For instance, in May 2024, according to the National Health Service (NHS), a UK-based government agency, in 2022-23, 32.5 million dental treatments were provided, reflecting a 23.2% increase compared to the previous year. Therefore, the rise in oral health issues is driving the growth of the salivary gland infections market.
How is the salivary gland infection market segmented?
The salivary gland infection market covered in this report is segmented –
1) By Diagnosis: Plain Radiography, Sialography, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Radionuclide Scintigraphy, High-resolution Ultrasonography, Other Diagnoses
2) By Treatment: Medications, Surgery, Aspiration, Home Care, Other Treatments
3) By End User: Hospitals And Clinics, Medical Research Centers, Academic Institutes, Other End User
Subsegments:
1) By Plain Radiography: X-ray Of Salivary Glands, Sialography With X-ray
2) By Sialography: Conventional Sialography, Digital Subtraction Sialography (DSS)
3) By Computed Tomography (CT): Non-contrast CT, Contrast-enhanced CT
4) By Magnetic Resonance Imaging (MRI): MRI without contrast, MRI With contrast (Dynamic MRI)
5) By Radionuclide Scintigraphy: Planar Scintigraphy, SPECT (Single Photon Emission Computed Tomography)
6) By High-resolution Ultrasonography: Standard Ultrasonography, Doppler Ultrasonography
7) By Other Diagnoses: Fine Needle Aspiration (FNA) Biopsy, Endoscopy, Salivary Flow Test
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/salivary-gland-infection-global-market-report
Who are the top competitors in the salivary gland infection market?
Major companies operating in the salivary gland infection market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., AstraZeneca plc, Novartis AG, GSK plc, Eli Lilly and Company, Gilead Sciences, Inc., Amgen Inc., FUJIFILM Holdings Corporation, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Astellas Pharma Inc., Sandoz International GmbH, Vertex Pharmaceuticals Incorporated, Incyte Corporation., Hikma Pharmaceuticals PLC, Lupin Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Vanda Pharmaceuticals Inc., Mylan N.V., Zydus Cadila Healthcare Ltd.
What significant trends should we anticipate in the salivary gland infection market over the forecast period?
Major companies operating in the salivary gland infections market are prioritizing technological advancements, particularly in minimally invasive procedures, to improve treatment outcomes, accelerate patient recovery, and enhance overall healthcare efficiency. Minimally invasive procedures involve smaller incisions and specialized tools, causing less tissue damage and promoting faster recovery. For instance, in March 2024, Amrita Hospital, an India-based healthcare institution, launched the Amrita Centre for minimally invasive salivary gland surgery, offering a groundbreaking treatment for salivary disorders through sialendoscopy, minimizing the need for surgery and preserving glandular function. The launch was highlighted by a two-day workshop showcasing expert demonstrations.
Which regional trends are influencing the salivary gland infection market, and which area dominates the industry?
North America was the largest region in the salivary gland infection market in 2024. The regions covered in the salivary gland infection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Salivary Gland Infection Market Report 2025 Offer?
The salivary gland infection market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Salivary gland infections are bacterial or viral infections that affect the salivary glands, leading to symptoms such as swelling, pain, and dry mouth. These infections occur in major glands such as the parotid, submandibular, and sublingual glands. They result from blockage, dehydration, or infections such as mumps.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21281
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
